The Motley Fool··Jonathan PoncianoPerceptive Advisors Doubles Down on Praxis, Stock Rallies 320%
Perceptive Advisors doubles investment in Praxis Precision Medicines to $588M, now largest holding. Stock surges 320% amid FDA submissions and strong cash position.
PRAXFDA approvalinstitutional investment